Avacta Group Plc (AVCT):製品パイプライン分析

GlobalDataが発行した調査報告書(DATA8010526)
◆英語タイトル:Avacta Group Plc (AVCT) - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010526
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年12月1日
◆ページ数:36
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products which include optim and sensipod. It also develops UCB celltech, which is an analytical instrument. Avacta’s sensipod is an in-clinical blood testing system that delivers ELISA tests. The company offers intellectual property relating to an alternative to antibodies. It develops reagents and diagnostics which are used in affinity chromatography, protein to protein interactions, immunoassay and rapid diagnostic test applications, among others. It operates in Wetherby, Cambridge and London. Avacta is headquartered in Wetherby, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Avacta Group Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Avacta Group Plc Company Overview 4
Avacta Group Plc Company Snapshot 4
Avacta Group Plc Pipeline Products and Ongoing Clinical Trials Overview 4
Avacta Group Plc – Pipeline Analysis Overview 7
Avacta Group Plc – Key Facts 7
Avacta Group Plc – Major Products and Services 8
Avacta Group Plc Pipeline Products by Development Stage 9
Avacta Group Plc Pipeline Products Overview 11
Depression Test 11
Depression Test Product Overview 11
Diagnostic Assay – Alzheimer’s Disease 12
Diagnostic Assay – Alzheimer’s Disease Product Overview 12
Diagnostic Test – ADHD 13
Diagnostic Test – ADHD Product Overview 13
Diagnostic Test – Bipolar Disorder 14
Diagnostic Test – Bipolar Disorder Product Overview 14
Point-Of-Care Diagnostic Test – Zika Virus 15
Point-Of-Care Diagnostic Test – Zika Virus Product Overview 15
Portable Pathogen Detection System 16
Portable Pathogen Detection System Product Overview 16
Rapid Diagnostic Test – Bacterial Strains 17
Rapid Diagnostic Test – Bacterial Strains Product Overview 17
Rapid Diagnostic Test – Infectious Diseases 18
Rapid Diagnostic Test – Infectious Diseases Product Overview 18
Schizophrenia Response Test 19
Schizophrenia Response Test Product Overview 19
Schizophrenia Side Effects Test 20
Schizophrenia Side Effects Test Product Overview 20
Avacta Group Plc – Key Competitors 21
Avacta Group Plc – Key Employees 22
Avacta Group Plc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Avacta Group Plc, Recent Developments 25
Nov 15, 2017: Covance to Present Affimer Data at European Conference 25
Oct 02, 2017: Avacta Establishes US Business Development Team 25
Aug 07, 2017: Avacta Group: Trading Update and Notice of Results 26
May 10, 2017: Avacta Group: Key Affimer patent to be granted in China 27
May 10, 2017: Avacta: Key Affimer patent to be granted in China 28
Apr 03, 2017: Excellent results for Affimer technology in Industry-standard immunogenicity study using human samples 28
Apr 03, 2017: Avacta Group: Interim results for the period ended 31 January 2017 29
Jan 20, 2017: AGM business update and notice of results 29
Nov 07, 2016: Avacta Group: World-Leading Cancer Stem cell Expert Joins Avacta Scientific Advisory Board 30
Oct 17, 2016: Avacta Group: Preliminary Results for the Year Ended 31 July 2016 31
Appendix 33
Methodology 33
About GlobalData 35
Contact Us 35
Disclaimer 36

List of Tables
Avacta Group Plc Pipeline Products and Ongoing Clinical Trials Overview 4
Avacta Group Plc Pipeline Products by Equipment Type 5
Avacta Group Plc Pipeline Products by Indication 6
Avacta Group Plc, Key Facts 7
Avacta Group Plc, Major Products and Services 8
Avacta Group Plc Number of Pipeline Products by Development Stage 9
Avacta Group Plc Pipeline Products Summary by Development Stage 10
Depression Test - Product Status 11
Depression Test - Product Description 11
Diagnostic Assay - Alzheimer's Disease - Product Status 12
Diagnostic Assay - Alzheimer's Disease - Product Description 12
Diagnostic Test - ADHD - Product Status 13
Diagnostic Test - ADHD - Product Description 13
Diagnostic Test - Bipolar Disorder - Product Status 14
Diagnostic Test - Bipolar Disorder - Product Description 14
Point-Of-Care Diagnostic Test - Zika Virus - Product Status 15
Point-Of-Care Diagnostic Test - Zika Virus - Product Description 15
Portable Pathogen Detection System - Product Status 16
Portable Pathogen Detection System - Product Description 16
Rapid Diagnostic Test - Bacterial Strains - Product Status 17
Rapid Diagnostic Test - Bacterial Strains - Product Description 17
Rapid Diagnostic Test - Infectious Diseases - Product Status 18
Rapid Diagnostic Test - Infectious Diseases - Product Description 18
Schizophrenia Response Test - Product Status 19
Schizophrenia Response Test - Product Description 19
Schizophrenia Side Effects Test - Product Status 20
Schizophrenia Side Effects Test - Product Description 20
Avacta Group Plc, Key Employees 22
Avacta Group Plc, Other Locations 23
Avacta Group Plc, Subsidiaries 23
Glossary 34

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Avacta Group Plc (AVCT):製品パイプライン分析(Avacta Group Plc (AVCT) - Product Pipeline Analysis, 2017 Update)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆